How often do we see
patients suffering from retinal vein occlusion in our daily
clinical routine? How often do we face the dilemma of it simply
not being clear which therapy we should suggest: haemodilution,
transfer to specialists in internal medicine, laser, surgery,
steroids, anti-VEGF? And above all, do we at all know the exact
pathophysiologic cause of this illness?
Bringing together experts in ophthalmology, vascular biology
and internal medicine, this symposium aims at emphasizing the
need for consensus on treatment recommendations and improving
interdisciplinary collaboration in investigating the pathophysiology
and |
|
|
sequelae of and therapeutic
approaches in retinal vein occlusion. Experts from these disciplines
will present therapeutic experience and the latest developments
in clinical and basic research ensuring a lively interdisciplinary
discussion.
Specials thanks go to the initiators, the sponsors and the audience
who will all contribute to this extraordinary scientific meeting
in the wonderful setting of the Festive Hall of the Austrian
Academy of Sciences.
Ursula Schmidt-Erfurth |
|
